In the years following the correction of the excessive deficit, the pace of adjustment the programme's MTO implied by the programme is broadly in line with the Stability and Growth Pact.

bends the line of the control serum the BLV antigen well without forming a visible precipitin line with the antigen; or

[Insert if applicable: A participant’s current and future claims towards the [insert name of the CB] arising from a credit balance on the PM account shall be transferred to the [insert name of the CB] as collateral, i.e. as a fiduciary transfer, for any current or future claim of the [insert name of the CB] the participant arising out of the [insert reference to the arrangement implementing these Conditions]. Such collateral shall be established by the mere fact that the funds have been credited to the participant’s PM account.]

[Insert if applicable: A participant's current and future claims towards the [insert name of the CB] arising from a credit balance on the PM account shall be transferred to the [insert name of the CB] as collateral (i.e. as a fiduciary transfer) for any current or future claim of the [insert name of the CB] the participant arising out of the [insert reference to the arrangement implementing these Conditions].

By way of derogation from paragraph 1, Estonia shall receive a financial contribution from the Community the cost of the work involved for the four years of data collection from 2005.

For the first three years of data collection Member States may receive a financial contribution from the Community the cost of the work involved.

These new instruments will be established along with new arrangements for the contribution of funds by BE the costs of the Nuclear Liabilities together with the management of BE’s nuclear liabilities.

A financial contribution from the Union of a total amount of 1555300 euros from budget line 17 04 02 the costs of the analyses provided for in Article 4(2) shall be granted to the Member States up to the maximum total amount for co-financing set out in Annex III.

on a financial contribution from the Community the costs of the vaccination against foot-and-mouth disease in the Netherlands in 2001

Member States shall receive a maximum financial contribution of 75 % from the Community the cost of carrying out the surveys defined in this Regulation, subject to the maximum amounts defined in paragraphs 3 and 4.

In line with the requirements arising from the case-law, in order to determine whether the Greek State’s financial contribution the costs of OTE’s VRS can be regarded as being in line with the behaviour of a private investor acting under normal market conditions, it is necessary to consider whether in similar circumstances a private investor of a size comparable to that of the State might have provided a similar financial contribution, namely the equivalent of 4 % of OTE’s shares [31].

Aid the cost of participating in trade fairs, or of studies or consultancy services needed for the launch of a new product or an existing product on a new market does not normally constitute export aid.

Aid the cost of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market does not normally constitute export aid.

The de minimis Regulation further clarifies in recital 6 that ‘aid the costs of participation in trade fairs or of studies or consultancy services needed for the launch of a new or existing product on a new market does not normally constitute export aid’.

Aid the costs of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market does normally not constitute export aid.

Aid the costs of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market in another Member State or a third country does not normally constitute export aid.

Aid the costs of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market in another Member State or a third country does not normally constitute export aid.

Aid the cost of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market should not normally constitute export aid.

Aid the costs of participation in trade fairs or of studies or consultancy services needed for the launch of a new or existing product on a new market should not normally constitute export aid.

Aid the cost of participating in trade fairs, or of studies or consultancy services needed for the launch of a new or existing product on a new market should not normally constitute export aid.